ArticleCommunications medicine2025
Artificial intelligence assisted clinical fluorescence imaging achieves in vivo cellular resolution comparable to adaptive optics ophthalmoscopy.
Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Open-Source Software Suite for Cell Detection and Segmentation in Adaptive Optics Retinal Imaging.Translational vision science & technology · 2026Article
- An update on recent advances in fluorescent materials for fluorescence molecular imaging: a review.RSC advances · 2025Review
- Artificial intelligence-assisted retinal imaging enables dense pixel sampling from sparse measurements.NPJ artificial intelligence · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdvancements in biomedical optical imaging have enabled researchers to achieve cellular-level imaging in the living human body. However, research-grade technology is not always widely available in routine clinical practice. In this paper, we incorporated artificial intelligence (AI) with standard clinical imaging to successfully obtain images of the retinal pigment epithelial (RPE) cells in living human eyes.
methodsFollowing intravenous injection of indocyanine green (ICG) dye, subjects were imaged by both conventional instruments and adaptive optics (AO) ophthalmoscopy. To improve the visibility of RPE cells in conventional ICG images, we demonstrate both a hardware approach using a custom lens add-on and an AI-based approach using a stratified cycleGAN network.
resultsWe observe similar fluorescent mosaic patterns arising from labeled RPE cells on both conventional and AO images, suggesting that cellular-level imaging of RPE may be obtainable using conventional imaging, albeit at lower resolution. Results show that higher resolution ICG RPE images of both healthy and diseased eyes can be obtained from conventional images using AI with a potential 220-fold improvement in time.
conclusionsThe application of using AI as an add-on module for existing instrumentation is an important step towards routine screening and detection of disease at earlier stages.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.